TA-65 and Aging Associated Microvascular Dysfunction
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorMedical College of Wisconsin
About this trial
The goal of this clinical trial is to test whether activation of telomerase with a dietary supplement (TA-65) improves microvascular function.
Eligibility criteria
Qualifiers
Healthy Adults 18 - 35 and 65+ years of age
Subjects with clinical diagnosis of CAD
Disqualifiers
36-64 years of age without clinical diagnosis of CAD
Self-reported habitual vigorous exercise (>20 min, 3 times per week, 1 yr)
Major Adverse Cardiovascular Event (MACE) in the last year (heart attack, stroke)
Heart Failure
Trial design
Treatments tested in this trial
- TA-65
- Placebo
Treatment groups
180 Participants
are divided into 2 treatment groupsLocations
This trial has no locations
Sponsors and collaborators
Medical College of Wisconsin
Lead sponsor
University of Louisville
Collaborator
Penn State University
Collaborator
Source ClinicalTrials.gov